Event

Christopher Straub

Novartis Institutes for Biomedical Research

Sympathy for the Devil: Taking IAP Antagonists from Research to the Clinic

Peter H. Seeberger

Max-Planck Institute for Colloids and Interfaces

Preventing and Curing Infectious Diseases: Carbohydrate Vaccines and Continuous Flow Synthesis